Sitagliptin vs Tislelizumab

## Sitagliptin vs Tislelizumab: Overview

This comparison examines the pharmacological differences between **Sitagliptin** and **Tislelizumab**.

## Mechanism of Action

**Sitagliptin**: DPP-4 inhibitor increasing incretin levels.

## Pharmacokinetics

**Half-life**: Sitagliptin — 12.4 hours; Tislelizumab — N/A.

## Chemical Properties

**Molecular Formula**: Sitagliptin — C16H15F6N5O; Tislelizumab — N/A.

**Molecular Weight**: Sitagliptin — 407.3140 g/mol; Tislelizumab — N/A.

**Type**: Sitagliptin — Small molecule; Tislelizumab — Antibody.